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INTRODUCTION
Laparoscopic pancreaticoduodenectomy (LPD) is a complicat-
ed and technically demanding surgical procedure. Since Gag-
ner and Pomp1 reported the first experience of LPD in 1994, 
LPD has been regarded as a technically feasible and safe sur-
gery by hepatobiliary and pancreas experts. Recently, more en-
couraging perioperative outcomes of LPD have been reported, 
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compared with open PD (OPD) in treating periampullary tu-
mors.2-6 Recently, the PADULAP randomized control trial dem-
onstrated that LPD was associated with a significantly lower 
duration of hospital stay and fewer Clavien-Dindo grade ≥3 com-
plications, while the resection margin and lymph node harvest 
were comparable.7 The meta-analysis by Chen, et al.8 also showed 
that LPD had lower transfusion rates, shorter hospital stay, and 
less blood loss. However, in general, the technical feasibility and 
safety of LPD still remain controversial.1,9
The inflammatory response secondary to obstructive chol-
angitis and pancreatitis can cause dense adhesion and unex-
pected local invasion of the tumor into major vessels, which do 
not favor safe and effective laparoscopic dissection. In addition, 
laparoscopic management of the soft remnant pancreas with 
small pancreatic duct is difficult, and these conditions are clin-
ically relevant to the development of a postoperative pancreatic 
fistula (POPF).10,11 Indeed, POPF can be a critical complication 
after pancreatectomy, and it was reported to occur in 3.8%–50% 
of cases in previous meta-analyses.2,3,12-14 Therefore, performing 
safe LPD to minimize postoperative morbidity is a major con-
cern in reconstruction during LPD. Certain intraoperative cir-
cumstances leading to difficult laparoscopic dissection and re-
constructions are considered main reasons for intraoperative 
conversion during LPD. 
Intraoperative conversion to OPD (converted PD, cPD) is a 
practical issue for both pancreatic surgeons and patients. PD is 
a very complicated surgical procedure, and timely intraopera-
tive conversion is essential to ensure the safety of LPD. Howev-
er, several previous reports lacked specific data on intraopera-
tive conversion during LPD.2,3,7,15 According to literature, it is 
estimated that the overall conversion rate during LPD is 3.1%–
24.1% in experienced surgeons.16-21 However, few studies have 
investigated the potential impact of intraoperative conversion 
during LPD on the perioperative clinical course. 
In this study, the perioperative clinical impact of intraoper-
ative conversion during LPD was evaluated, and the potential 
predictive factors for intraoperative conversion were also inves-
tigated. This study is expected to assist in selecting appropriate 
patients to avoid unnecessary intraoperative conversion and 
achieve the goal of safe LPD. 
MATERIALS AND METHODS
Study design 
The medical records of patients who underwent LPD by single 
surgeon from September 2012 to July 2018 were retrospectively 
reviewed. Both benign and malignant lesions were included. 
The selection criteria for LPD included patients in good gener-
al condition who were able to endure long operation time for 
pneumoperitoneum, with no history of upper gastrointestinal 
surgery with resectable periampullar tumors and without dis-
tant metastasis nor overt major vessel involvement on preop-
erative radiological images. Initial OPD was indicated when 
patients who refused to have LPD, and they had tumor condi-
tions expected to undergo intraoperative conversion, such as 
high risk of tumor invasion around the major vascular struc-
tures, and severe intraabdominal adhesion. Intraoperative con-
version was defined as resection that had to be completed by 
laparotomy due to technical difficulties or failure to progress 
during LPD. The primary end point of this study was to evalu-
ate the perioperative adverse impacts of unplanned intraop-
erative conversion during LPD (cPD) by comparative analysis 
with initial OPD. The costs associated with unplanned conver-
sion were also compared.
Data collection 
The patients’ demographic parameters, including age, Ameri-
can Society of Anesthesiologists (ASA) physical status, body 
mass index (BMI), and neoadjuvant therapy, were evaluated. 
The reoperation rate, readmission rate, postoperative hemor-
rhage rate, occurrence of delay gastric emptying and POPF (de-
fined by the International Study Group on Pancreatic Fistula, 
ISGPF),22 30-day mortality, and morbidities were assessed. Fur-
thermore, the transfusion rate, short-term surgical outcome (in-
cluding transfusion rate), number of retrieved lymph nodes, and 
R-status of the resection specimen were also evaluated. In addi-
tion, we examined the reasons for unplanned conversion, such 
as major vascular invasion, failure to progress due to adhesion, 
easy bleeding tendency, and anatomical anomalies. The Insti-
tutional Review Board of Severance Hospital approved this study 
protocol (IRB No. 4-2018-0863).
Surgical procedure 
During LPD, the resection and reconstruction of pancreatico-
jejunostomy and hepaticojejunostomy were performed intra-
corporeally. The surgical specimen was retrieved through a mini-
laparotomy wound by extending the umbilical port site where 
the duodenojejunostomy was performed.5,23-25
Statistical analysis 
Continuous variables were described as the mean±standard de-
viation, and categorical variables were described as the frequen-
cy (%). Categorical variables were analyzed using the chi-squared 
test, and the Student’s t-test was used for continuous variables. 
To identify the predictive factors for conversion, multivariate 
analyses were performed for different variables using a logistic 
regression model. p-values <0.05 were considered statistically 
significant. All statistical analyses were performed using the IBM 
SPSS Statistics 23.0 (IBM Corp., Armonk, NY, USA).
RESULTS
General characteristics of the patients
From September 2012 to July 2018, a total of 171 LPDs were per-
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formed; 93 patients were male and 78 patients were female, with 
an age range of 61.1±12.0 years. Among them, 155 patients (91%) 
underwent laparoscopic pylorus-preserving pancreaticoduo-
denectomy (Lap-PPPD), 15 patients (9%) underwent laparo-
scopic total pancreatectomies (Lap-TP), and 1 patient (0.6%) 
underwent conventional pancreaticoduodenectomy (Lap-PD). 
Only 4 patients (2%) received neoadjuvant therapy before surgery. 
Over 70% of the surgeries were performed for malignant dis-
eases. Among these, common bile duct cancer was the most 
common (40 patients, 23%), followed by the ampulla of Vater 
cancer (35 patients, 20%). In benign and low-grade malignant 
tumors of the pancreas, intraductal papillary mucinous neo-
plasms were the most common (26 patients, 15%) (Table 1).
Incidence and reasons for intraoperative conversion 
during LPD 
Among the 171 attempted LPDs, 31 patients had to convert to 
an open approach during LPD (cPD) and the overall conver-
sion rate was 19.3%. Moreover, the intraoperative conversion 
rate during LPD was found to be steady over time (range, 13.3%–
42.8%, chi-square, Fisher’s exact test, linear-to-linear associa-
tion, p=0.013) (Fig. 1).
Failure of dissection due to severe adhesion was the most 
common reason for conversion during LPD (12 patients, 38.7%), 
followed by suspicion of major vessel [superior mesenteric vein 
(SMV)/portal vein (PV)] invasion (7 patients, 22.5%) (Table 2). 
The main reasons for adhesion were severe inflammation due 
to cholangitis, pancreatitis, post neoadjuvant therapy, desmo-
plastic changes surrounding pancreatic head, and direct tumor 
invasion to major vasculatures. In addition, combined segmen-
tal resection of the colon was necessary in two conversion cases 
due to incidental ischemic change of colon following excision 
or shaving of colonic mesentery for tumor invasion. 
Predictive factors for intraoperative conversion 
during LPD 
In univariate analysis, age (p=0.013), sex (p=0.019), ASA physi-
cal status (p=0.039), total bilirubin (p=0.06), size of the pancre-
atic duct (p=0.047), and pancreatic texture (p=0.015) were as-
sociated with conversion during LPD. Diagnosis, neoadjuvant 
therapy, BMI, and the size of bile duct were not found to be re-
lated to conversion (p>0.05) (Table 3). On multivariate analysis, 
age {Exp(β)=1.044 [95% confidence interval (CI): 1.001–5.660], 
p=0.044} and pancreatic texture [hard pancreas; Exp(β)=2.431 
(95% CI: 1.044–5.660), p=0.039] were found to be independent 
Table 1. Diagnosis in 171 Laparoscopic Pancreaticoduodenectomy 
Cases
CBD cancer 40 (23)
AoV cancer 35 (20)
PDAC 29 (17)
IPMN 26 (15)
Metastatic cancer 15 (9)  
NET 14 (8)
AoV adenoma 10 (6)
SPN 6 (4)
GIST 5 (3)





Data are presented as n (%).
CBD, common bile duct; AoV, ampulla of vater; PDAC, pancreatic ductal ade-
nocarcinoma; IPMN, intraductal papillary mucinous neoplasm; NET, neuroen-
docrine tumor; SPN, solid pseudopapillary neoplasm; GIST, gastrointestinal 
stromal tumor; SCN, serous cystic neoplasm.


































Table 2. Reasons for Conversion during Lap-PD 
Reasons for conversion Frequency (%)
Failure to progress due to severe adhesion 12 (39)
Suspicious SMV/PV invasion 7 (23)
Hepatic artery invasion 3 (9.6)
Combined colon segmental resection 2 (6.4)
Internal obesity 2 (6.4)
Consecutive positive bile duct resection margin 2 (6.4)
Sustained high pCO2 2 (6.4)
Vascular anomaly (RHA penetrating pancreatic head) 1 (<3.2)
Suspicious IVC invasion 1 (<3.2)
Easy bleeding tendency 1 (<3.2)
Small bowel internal rotation 1 (<3.2)
Lap-PD, laparoscopic pancreaticoduodenectomy; SMV, superior mesenteric 
vein; PV, portal vein; RHA, right hepatic artery; IVC, Inferior vena cava.
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factors for predicting conversion during LPD.
When correlating preoperatively detectable parameters for 
predicting the pancreatic texture, age (p=0.041), diagnosis (p= 
0.024 and <0.001), ASA physical status (p=0.013), bile duct size, 
and pancreatic duct size (p<0.001) were significantly associat-
ed with hard remnant pancreas (Table 4). Subsequent multi-
variate analysis showed that pancreatic texture was indepen-
dently associated with pancreatic duct size [Exp(β)=1.473 (95% 
CI: 1.234–1.758), p<0.001] and diagnosis of pancreatic cancer 
[Exp(β)=3.852 (95% CI: 1.440–10.305), p=0.007].
Clinical adverse impact of intraoperative conversion 
during LPD
When cPD and initial OPD were compared, age, sex, estimated 
blood loss, transfusion rate, number of retrieved lymph nodes, 
and R-status showed no significant difference between the two 
groups (p>0.05) (Table 5). Malignant disease (p=0.017), pancre-
atic cancer (p=0.044), and neoadjuvant treatment (p=0.024) were 
more frequent in initial OPD than in cPD. However, the cPD 
group had a significantly longer operating time (516.8±96.6 min 
vs. 449.9±102.9 min, p=0.001). In addition, the incidence of post-
pancreatectomy hemorrhage (PPH) (p=0.008) and reoperation 
(p=0.010) were shown to be significantly higher in the cPD group 
(Table 6). Regarding PPH, one patient required transfusion of 






Age (yr) 59.9±12.1 65.7±10.9 0.013
Sex (male/female) 69/69 24/9 0.019
Diagnosis 1 (benign &  
  low-grade/malignant)
50/88 9/24 0.609
Diagnosis 2 (PC/non-PC) 21/117 8/25 0.215
ASA (1/2) 13/77 0/17 0.039
ASA (3/4) 48/0 15/1
Neo-Tx (no/yes) 135/3 32/1 0.579
Total bilirubin 1.0±0.9 1.41.1 0.076
BMI 23.5±2.9 23.0±2.5 0.431
BD-size 1.2±1.0 1.3±0.5 0.403
PD-size 3.6±2.2 4.8±3.1 0.047
Pancreatic texture  
  (soft/hard)
96/30 16/14 0.015
PD, pancreaticoduodenectomy; LPD, laparoscopic pancreaticoduodenectomy; 
PC, pancreatic cancer; ASA, American Society of Anesthesiologists; Neo-Tx, 
neoadjuvant treatment; BMI, body mass index; BD-size, bile duct size; PD-
size, pancreatic duct size.
Table 6. Adverse Impact of Converting PD on Postoperative Course
Converting PD 
(n=33)
Initial open PD 
(n= 117)
p value
POPF (no/yes) 28/5 98/19 0.463
POBF (no/yes) 32/1 113/4 1.000
DGE (no/yes) 26/7 99/18 0.598
PPH (no/yes) 29/4 116/1 0.008
LOH 21.7±7.5 17.9±8.6 0.140
Reoperation (no/yes) 30/3 117/0 0.010
Readmission (no/yes) 29/4 108/9 0.484
30-day mortality (no/yes) 33/0 117/0 NA
90-day mortality (no/yes) 33/0 117/0 NA
Cost (USD) 21886.4±10594.4 17168.9±4973.1 0.018
PD, pancreaticoduodenectomy; POPF, postoperative pancreatic fistula; POBF, 
postoperative bile fistula; DGE, delayed gastric emptying; PPH, postpancre-
atectomy hemorrhage; LOH, length of hospital stay.
Table 5. Demographics between Converting PD and Initial Open PD
Converting PD 
(n=33)
Initial open PD 
(n=117)
p value
Age (yr) 65.7±10.9 64.1±9.9 0.392
Sex (male/female) 24/9 71/46 0.227
Diagnosis 1 (benign &  
  low-grade/malignant)
9/24 9/108 0.017
Diagnosis 2 (PC/non-PC) 8/25 52/65 0.044
ASA (1/2/3/4) 0/17/15/1 7/53/51/6 0.882
Neo-Tx (no/yes) 32/1 94/23 0.028
Total bilirubin 1.4±1.1 1.3±1.2 0.631
BMI 23.0±2.5 23.3±3.1 0.744
Operating time 516.8±96.6 449.9±102.9 0.001
EBL 645.5±559.4 562.1±439.2 0.368
Transfusion (no/yes) 30/3 102/15 0.764
Tumor size 3.4±2.1 2.9±1.6 0.224
No. of retrieved LNs 12.4±7.5 13.9±8.9 0.380
No. of metastatic LNs 1.9±2.8 1.6±2.9 0.522
R-status 0/33 4/111 0.575
PC, pancreatic cancer; ASA, American Society of Anesthesiologists; Neo-Tx, 
neoadjuvant treatment; BMI, body mass index; PD, pancreaticoduodenecto-







Age (yr) 59.8±12.1 64.1±11.1 0.041
Sex (male/female) 60/52 27/17 0.474
Diagnosis 1 (benign &  
  low-grade/malignant)
7/34/71 0/7/37 0.024
Diagnosis 2 (PC/non-PC) 11/101 17/44 <0.001
ASA (1/2/3/4) 12/67/33/0 1/20/22/1 0.013
Neo-Tx (no/yes) 110/2 42/2 0.578
Total bilirubin 1.0±0.8 1.3±1.1 0.060
BMI 23.5±3.1 23.5±2.6 0.965
BD-size 1.1±0.4 1.4±1.1 0.042
PD-size 3.1±2.0 5.5±2.5 <0.001
PC, pancreatic cancer; ASA, American Society of Anesthesiologists; Neo-Tx, 
neoadjuvant treatment; BMI, body mass index; BD-size, bile duct size; PD-
size, pancreatic duct size.
*Laparoscopic TP were excluded.
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three units of packed red blood cells during the postoperative 
period. The other two patients were associated with POPF, which 
required interventional angiography and embolization. An-
other patient required reoperation for bleeding from the liver 
bed due to detachment of the gallbladder. It was also observed 
that emergent diverting loop ileostomy was required in a case 
of combined colon resection during cPD, and secondary wound 
closure was necessary in one patient. Finally, the medical cost 
was reported to be much higher in the conversion group than 
in the initial OPD group {24591443±11903768.2 (￦) [21886.4± 
10594.4 ($)] vs. 19290897.2±5587761.9 (￦) [17168.9±4973.1 ($)]; 
p=0.018} (Table 6). 
DISCUSSION
Since the first LPD was performed in 2008 in our center, the an-
nual number of LPD has steadily increased. However, the over-
all conversion rate was estimated to be 19.3% in this study, which 
is similar to that in other studies. To the best of our knowledge, 
no previous study has directly compared perioperative outcomes 
between cPD and initial OPD to investigate the potential clini-
cal impact of cPD. Therefore, this study is thought to be the first 
to investigate the potential adverse impact of conversion during 
LPD. In this study, the conversion group had a longer operating 
time, higher occurrence of postoperative hemorrhage, higher 
reoperation rate, and consequently higher medical costs. For the 
patients’ safety during LPD, unnecessary intraoperative con-
version during LPD should be avoided. This can be ensured by 
careful preoperative patient selection. Therefore, prediction of 
the potential risk of intraoperative conversion before surgery 
is important. 
To ensure safety of the patients, surgeons should consider the 
potential adverse impacts of intraoperative conversion during 
LPD. The average conversion rate in LPD is reported to be around 
20%–25%. Palanivelu, et al.20 performed the first RCT compar-
ing LPD with OPD for periampullary cancer, and showed a 
shorter hospital stay and relatively low conversion rate of only 
3.1%. The PADULAP randomized controlled trial showed that 
although LPD was associated with a shorter length of hospital 
stay, the conversion rate was 23.5% (8/34).7 However, with ac-
cumulating experience, conversion rate can be stabilized, 
which is supported by the present data. In this study, it appears 
that the intraoperative conversion was reduced as more expe-
riences were accumulated (range, 13.3%–42.8%, chi-square, 
Fisher’s exact test, linear-to-linear association, p=0.013). 
The consequences of unplanned conversion in other laparo-
scopic surgeries have been evaluated in many previous studies, 
such as the impact of conversion during laparoscopic hepatec-
tomy. The study by Silva, et al.26 showed higher transfusion rates, 
longer hospital stay, and higher morbidity in unplanned con-
version group. Furthermore, Belizon, et al.27 showed that the 
overall conversion rate in laparoscopic colorectal resection was 
19.6%, and the morbidity was significantly higher, especially in 
terms of wound infection and longer hospital stay. In contrast, 
the study by Casillas, et al.28 showed no significant differences in 
operative time, length of stay, costs, or unexpected remissions. 
Despite these previous studies, the impact of intraoperative 
conversion during LPD has not been fully investigated. Recent-
ly, Torphy, et al.16 evaluated the clinical impact of conversion to 
the open approach in their subgroup analysis of minimally in-
vasive PD. They found that 84 robotic pancreaticoduodenecto-
mies (RPD, 15.3%) and 823 LPD (25.7%) were converted to OPD. 
The LPD patients requiring conversion had no significant dif-
ferences in terms of 90-day mortality compared to those who 
completed LPD [odds ratio (OR), 1.48; 95% CI, 0.97–2.24]. For 
RPD, while the conversion group showed a 4-fold increase in 
90-day mortality, no significant difference observed in the con-
version rate over time (p=0.605). Furthermore, the lower the 
volume of minimally invasive PD centers, the higher the con-
version rate; therefore, the conversion group likely had longer 
operative times and more blood loss. A recent multicenter study29 
found that elective conversion (e.g., vascular involvement) in 
minimally invasive distal pancreatectomy for pancreatic ductal 
adenocarcinoma was associated with comparable short-term 
oncological outcomes to OPD, while emergency conversions 
(e.g., bleeding) were associated with worse outcomes over both 
short and long terms. This finding suggests that careful patient 
selection and timely conversion are required to safely conduct 
minimally invasive pancreatectomy. 
The current study shows that both age and pancreatic texture 
were independent factors that could predict conversion during 
LPD. Practically, pancreatic texture (hard pancreas) can be pre-
dicted by pancreatic duct size [Exp(β)=1.473 (95% CI: 1.234–
1.758), p<0.001] and diagnosis of pancreatic cancer [Exp(β)= 
3.852 (95% CI: 1.440–10.305), p=0.007] in preoperative clinical 
setting. Moreover, recent literatures have also successfully dem-
onstrated the safety of short-term and long-term oncologic out-
comes of LPD for pancreatic cancers.30 However, it is believed 
that both the accumulation of laparoscopic experience and well-
organized selection criteria should be based on excellent clinical 
results. Therefore, although LPD for pancreatic cancer is con-
sidered to be feasible, it should be the last indication only when 
matured experience and technical skills are fully obtained.
Especially in pancreatic cancer, resectability is determined 
by the degree of the vascular invasion adjacent to the pancreas 
[PV/SMV, superior mesenteric artery (SMA)], and successful lap-
aroscopic resection depends on the dissection of the pancreas 
from the major vessels. Resectability can be evaluated preoper-
atively by various imaging modalities, such as CT scan or endo-
scopic ultrasonography (EUS). However, there are many cases 
where image findings do not correlate with intraoperative find-
ings. In our study, there were seven cases of open conversion 
due to SMV/PV invasion. However, in preoperative CT scan, 
SMV invasion of less than 180 degrees was suspected in only 
three cases. In the other four cases, the tumor did not invade or 
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abutted SMV/PV in preoperative CT scan. At present, it is con-
sidered impossible to fully predict the possibility of laparoscop-
ic resection through preoperative image studies. However, the 
common point of open conversion cases is that all of the patients 
have undergone biopsy of the tumor via EUS or endoscopic ret-
rograde cholangiopancreatography, which can result in tissue 
injury and inflammation. The adhesion due to inflammation 
can mimic tumor invasion to the major vessels. It is recommend-
ed to avoid unnecessary biopsy for lesions requiring surgical 
excision regardless of the biopsy results.
Torphy, et al.16 mainly reported factors associated with a high-
er risk of conversion in a minimally invasive group; these includ-
ed the male sex, tumor size >34 mm, and a low PD volume cen-
ter. In this study, the patients’ BMI was around 23 kg/m2, which 
was not associated with conversion during LPD (23.0±2.5 vs. 
23.3±3.1, p=0.744). However, Cesaretti, et al.31 recommended that 
patients with a BMI >40 m/kg2 and locally advanced lesions 
should be reconsidered for LPD. Although the present study 
failed to reveal the impact of BMI on intraoperative conversion, 
according to our experiences, in patients with high BMI, it was 
difficult to ensure an operative field, especially when dissecting 
uncinate processes due to the bulky omentum and colon hiding 
in this area, which make the surgery very difficult. In particular, 
this area, known as the retroperitoneal margin (SMA lateral mar-
gin), is oncologically very important in patients with pancre-
atic cancer. Therefore, BMI should also be considered as one of 
the preoperative selection criteria for LPD. In the near future, 
in order to precisely predict the potential risk of conversion dur-
ing LPD, correlation between preoperative visceral fat mea-
surement and conversion risk should be further investigated. 
Our study had several limitations. First, this was a retrospec-
tive study with a limited number of patients. In addition, se-
lection bias should be considered when interpreting the study 
results. However, the present study demonstrated that intra-
operative conversion during LPD can have negative impacts 
on the postoperative clinical course. Therefore, preoperative 
patients selection and technical proficiency are required to 
perform safe LPD. Considering the patients’ general condition, 
tumor biology, anatomic relationship with the major vascular 
structures, and the surgeons’ technique, the surgical approach 
can be individualized to improve safety. A large population-
based multicenter collaborative study needs to be performed 
in the near future to validate the current observations.
Another limitation of our study was that it only involved a sin-
gle surgeon’s experience on minimal invasive pancreatectico-
duodenectomy in our institute; therefore, the study size was 
not large enough. Since minimally invasive pancreatecticodu-
odenectomy requires higher level of laparoscopic technical skills 
and a long learning curve, our institute only had one surgeon 
who was experienced enough to perform the procedure. How-
ever, the results of our study did show some significance on the 
morbidities of unexpected conversion to open surgery. With 
the advancement in the laparoscopic techniques worldwide, 
a growing number of pancreatic surgeons are performing lap-
aroscopic or even RPD. A multicenter collaborative study would 
be worthwhile to justify the safety of unplanned conversion to 
open surgery for minimally invasive LPD performed by differ-
ent surgeons, and to prevent its adverse effects. 
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